Home › Glycogen Storage Disease Type II › Virginia › Arlington
Glycogen Storage Disease Type II clinical trials in Arlington, VA
5 studies for Glycogen Storage Disease Type II are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of DNL952 in Adult Participants With Late-Onset Pompe Disease
RecruitingPhase 1
- The Lysosomal & Rare Disorders Research & Treatment Center, Fairfax · 11 mi away
Pompe Disease Registry Protocol
RecruitingObservational study
- O & O Alpan- Site Number : 840025, Fairfax · 11 mi away
Study of S-606001 as an Add-on to Enzyme Replacement Therapy (ERT) in Participants With Late-onset Pompe Disease (LOPD)
RecruitingPhase 2
- Lysosomal and Rare Disorders Research and Treatment Center (LDRTC), Fairfax · 11 mi away
Pompe Pregnancy Sub-Registry
RecruitingObservational study
- O & O Alpan- Site Number : 840025, Fairfax · 11 mi away
A Global Prospective Observational Registry of Patients With Pompe Disease
RecruitingObservational study
- Lysosomal and Rare Disorders Research and Treatment Center, Inc., Fairfax · 11 mi away
Glycogen Storage Disease Type II trials in other cities
- Durham, NC8 studies
- St. Louis, MO5 studies
- Irvine, CA5 studies
- Atlanta, GA4 studies
- New York City, NY4 studies
- Pittsburgh, PA4 studies
- Philadelphia, PA4 studies
- Phoenix, AZ3 studies
- Indianapolis, IN3 studies
- Jacksonville, FL3 studies
- Cincinnati, OH3 studies
Other studies in Arlington
- Non-Small Cell Lung Cancer104 studies
- Metastatic Cancer53 studies
- Colorectal Cancer52 studies
- Cancer (all types)48 studies
- Breast Cancer46 studies
- Ovarian Cancer46 studies
- Lung Cancer41 studies
- Endometrial Cancer39 studies
- Pancreatic Cancer33 studies
- Head and Neck Squamous Cell Carcinoma26 studies
- Small Cell Lung Cancer23 studies
- Triple-Negative Breast Cancer20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.